Gene: ARMC1
Official Full Name: armadillo repeat containing 1provided by HGNC
Gene Summary: Predicted to enable metal ion binding activity. Involved in intracellular distribution of mitochondria. Located in cytosol and mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19669 | ARMC1 Knockout cell line (HeLa) | Human | ARMC1 | 1:3~1:6 | Negative | Online Inquiry |
KO19670 | ARMC1 Knockout cell line (HCT 116) | Human | ARMC1 | 1:2~1:4 | Negative | Online Inquiry |
KO19671 | ARMC1 Knockout cell line (HEK293) | Human | ARMC1 | 1:3~1:6 | Negative | Online Inquiry |
KO19672 | ARMC1 Knockout cell line (A549) | Human | ARMC1 | 1:3~1:4 | Negative | Online Inquiry |
ARMC1 Gene Knockout Cell Lines are precisely engineered cellular models that facilitate the study of the ARMC1 gene's role in various biological processes. These knockout cell lines are created using CRISPR-Cas9 technology, leading to the complete ablation of the ARMC1 gene. By eliminating the function of ARMC1, researchers are provided with a unique opportunity to investigate the gene’s contributions to cellular signaling, metabolism, and its implications in disease models, ultimately advancing our understanding of its biological significance.
The key function of ARMC1 Gene Knockout Cell Lines lies in their ability to mimic pathological conditions where ARMC1 is dysfunctional or absent. By utilizing these cell lines, scientists can elucidate the underlying mechanisms through which ARMC1 influences cellular processes, enabling detailed investigations into its roles in diseases such as cancer, neurodegeneration, and metabolic disorders. The loss of ARMC1 can lead to alterations in cellular pathways, making these cell lines an invaluable tool for hypothesis-driven research and drug discovery.
The scientific importance of ARMC1 gene knockout models extends into both research and clinical settings, as the insights gleaned from these studies may pave the way for novel therapeutic interventions. Researchers can use these cell lines to screen potential drugs, identify biomarkers, and better understand tissue-specific responses to the loss of ARMC1 function.
Compared to traditional knockout methodologies, the ARMC1 Gene Knockout Cell Lines offer several advantages, including greater efficiency, reproducibility, and specificity in gene targeting. These cell lines eliminate the variability often seen in transient transfection methods, providing consistent and reliable results across experiments. Furthermore, the CRISPR-Cas9 technology employed allows for precise modifications, ensuring that experimental outcomes are less confounded by off-target effects.
For researchers and clinicians, the availability of ARMC1 Gene Knockout Cell Lines represents a powerful asset in clinical research, potentially leading to groundbreaking discoveries in genetic and cellular biology. By enabling the exploration of ARMC1’s functions in a controlled environment, these tools are essential for advancing our understanding of complex biological systems.
Our company specializes in the development of cutting-edge genetic tools and cell lines tailored for research applications. With years of expertise in the field, we are committed to providing high-quality biological products that empower scientists in their quest for innovative solutions in life sciences research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.